Patents Assigned to VISION-7 GMBH
  • SECRETABLE HIV ENTRY INHIBITORY PEPTIDES FOR THERAPY OF HIV INFECTION
    Publication number: 20110027240
    Abstract: The invention relates to gene therapy of HIV infection by providing to a patient a nucleic acid for the expression of in vivo secretable peptides that prevent entry of the virus into the cell. The invention makes available nucleic acids and vectors containing the same that code for a fusion protein which contains two HIV entry inhibitory peptides which are connected by a cleavable linker, wherein the peptides are preferably derived from the second (C) heptad repeat of the gp41 protein of HIV.
    Type: Application
    Filed: January 9, 2009
    Publication date: February 3, 2011
    Applicants: VISION-7 GMBH, CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEOR-SPEYE
    Inventors: Dorothee von Laer, Lisa Egerer